{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:30:25Z","timestamp":1780446625008,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100009330","name":"Medical Science and Technology Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["A202142"],"award-info":[{"award-number":["A202142"]}],"id":[{"id":"10.13039\/501100009330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["nos.81872902, 82073917"],"award-info":[{"award-number":["nos.81872902, 82073917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Guangdong Province","award":["2023A1515011525"],"award-info":[{"award-number":["2023A1515011525"]}]},{"name":"Lymphoma Research Fund of China Anti-Cancer Association and the Sun Yat-sen University Cancer Center Clinical Research 308 Program","award":["nos. 2014-fxy-106 and 2016-fxy-079"],"award-info":[{"award-number":["nos. 2014-fxy-106 and 2016-fxy-079"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00277-024-05782-0","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T04:01:49Z","timestamp":1721102509000},"page":"4135-4144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Circulating tumor DNA assisting lymphoma genetic feature profiling and identification"],"prefix":"10.1007","volume":"103","author":[{"given":"Hongbiao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxiang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"key":"5782_CR1","unstructured":"Jamil A, Mukkamalla SKR, Lymphoma (2022) StatPearls [Internet]: StatPearls Publishing"},{"issue":"19","key":"5782_CR2","first-page":"3724","volume":"116","author":"M Sant","year":"2010","unstructured":"Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O et al (2010) Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood. J Am Soc Hematol 116(19):3724\u20133734","journal-title":"J Am Soc Hematol"},{"key":"5782_CR3","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International agency for research on cancer Lyon"},{"issue":"11","key":"5782_CR4","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1016\/j.clml.2021.06.012","volume":"21","author":"Z Ahmed","year":"2021","unstructured":"Ahmed Z, Afridi SS, Shahid Z, Zamani Z, Rehman S, Aiman W et al (2021) Primary mediastinal B-cell lymphoma: a 2021 update on genetics, diagnosis, and novel therapeutics. Clin Lymphoma Myeloma Leuk 21(11):e865\u2013e75","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5782_CR5","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.critrevonc.2017.01.009","volume":"113","author":"M Martelli","year":"2017","unstructured":"Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PW (2017) Primary mediastinal large B-cell lymphoma. Crit Rev Oncol\/Hematol 113:318\u2013327","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"Supplement 1","key":"5782_CR6","doi-asserted-by":"publisher","first-page":"12106","DOI":"10.1182\/blood-2022-169045","volume":"140","author":"M Garg","year":"2022","unstructured":"Garg M, Takyar J, Dhawan A, Saggu G, Agrawal N, Hall A et al (2022) Diffuse large B-Cell lymphoma (DLBCL): a structured literature review of the Epidemiology, Treatment guidelines, and real-world treatment patterns. Blood 140(Supplement 1):12106\u201312107","journal-title":"Blood"},{"issue":"5","key":"5782_CR7","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al (1994) A revised european-american classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361\u20131392","journal-title":"Blood"},{"key":"#cr-split#-5782_CR8.1","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E et al (2022) Correction:The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms Leukemia."},{"key":"#cr-split#-5782_CR8.2","unstructured":"36 (7): 1720-1748. Leukemia. 2023;37(9):1944-51"},{"issue":"11","key":"5782_CR9","first-page":"1229","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC et al (2022) The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood J Am Soc Hematol 140(11):1229\u20131253","journal-title":"Blood J Am Soc Hematol"},{"key":"5782_CR10","doi-asserted-by":"crossref","unstructured":"Joos S, Ota\u00f1o-Joos MI, Ziegler S, Bruderlein S, Du Manoir S, Bentz M et al (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571"},{"issue":"13","key":"5782_CR11","first-page":"2062","volume":"123","author":"DD Twa","year":"2014","unstructured":"Twa DD, Chan FC, Ben-Neriah S, Woolcock BW, Mottok A, Tan KL et al (2014) Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma. Blood J Am Soc Hematol 123(13):2062\u20132065","journal-title":"Blood J Am Soc Hematol"},{"issue":"3","key":"5782_CR12","first-page":"549","volume":"60","author":"S Joos","year":"2000","unstructured":"Joos S, K\u00fcpper M, Ohl S, Von Bonin F, Mechtersheimer G, Bentz M et al (2000) Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30\u2009+\u2009Hodgkin cells. Cancer Res 60(3):549\u2013552","journal-title":"Cancer Res"},{"issue":"18","key":"5782_CR13","first-page":"2036","volume":"131","author":"E Vigan\u00f2","year":"2018","unstructured":"Vigan\u00f2 E, Gunawardana J, Mottok A, Van Tol T, Mak K, Chan FC et al (2018) Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation. Blood. J Am Soc Hematol 131(18):2036\u20132046","journal-title":"J Am Soc Hematol"},{"issue":"22","key":"5782_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1182\/blood.V114.22.968.968","volume":"114","author":"D Jones","year":"2009","unstructured":"Jones D, Windham J, Stewart B, Fayad L, Rodriguez A, Hagemeister FB (2009) Differential JAK-STAT pathway activation in primary Mediastinal large B-Cell lymphoma: two subgroups with Differential Cytokine activation patterns and predicted responses to kinase inhibitors. Blood 114(22):968","journal-title":"Blood"},{"issue":"4","key":"5782_CR15","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41375-021-01204-6","volume":"35","author":"MA Weniger","year":"2021","unstructured":"Weniger MA, K\u00fcppers R (2021) Molecular biology of Hodgkin lymphoma. Leukemia 35(4):968\u2013981","journal-title":"Leukemia"},{"issue":"5","key":"5782_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"R Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann M-L, Bohle V, Martin-Subero JI, Hartmann S, Mechtersheimer G et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206(5):981\u2013989","journal-title":"J Exp Med"},{"issue":"12","key":"5782_CR17","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1097\/PAS.0000000000000297","volume":"38","author":"M Shi","year":"2014","unstructured":"Shi M, Roemer MG, Chapuy B, Liao X, Sun H, Pinkus GS et al (2014) Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain. Am J Surg Pathol 38(12):1715","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"5782_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.hoc.2009.04.013","volume":"23","author":"B Schnitzer","year":"2009","unstructured":"Schnitzer B (2009) Hodgkin lymphoma. Hematol Oncol Clin N Am 23(4):747\u2013768","journal-title":"Hematol Oncol Clin N Am"},{"issue":"4","key":"5782_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.3390\/diagnostics12040963","volume":"12","author":"A Santisteban-Espejo","year":"2022","unstructured":"Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, Atienza-Cuevas L, Moran-Sanchez J, Fernandez-Valle MC et al (2022) The need for standardization in next-generation sequencing studies for classic Hodgkin lymphoma: a systematic review. Diagnostics 12(4):963","journal-title":"Diagnostics"},{"issue":"22","key":"5782_CR20","first-page":"2413","volume":"131","author":"V Spina","year":"2018","unstructured":"Spina V, Bruscaggin A, Cuccaro A, Martini M, Di Trani M, Forestieri G et al (2018) Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma. Blood J Am Soc Hematol 131(22):2413\u20132425","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"5782_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3324\/haematol.2019.237719","volume":"106","author":"V Camus","year":"2021","unstructured":"Camus V, Viennot M, Lequesne J, Viailly P-J, Bohers E, Bessi L et al (2021) Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. Haematologica 106(1):154","journal-title":"Haematologica"},{"key":"5782_CR22","doi-asserted-by":"crossref","unstructured":"Kamaeva IA, Novikova IA, Lysenko IB, Timoshkina NN, Nikolaeva NV, Kapuza EA et al (2022) Newly identified molecular and genetic characteristics of primary mediastinal large B-cell lymphoma. American Society of Clinical Oncology","DOI":"10.1200\/JCO.2022.40.16_suppl.e19580"},{"issue":"9","key":"5782_CR23","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1038\/s41375-022-01618-w","volume":"36","author":"EM Lauer","year":"2022","unstructured":"Lauer EM, Mutter J, Scherer F (2022) Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research. Leukemia 36(9):2151\u20132164","journal-title":"Leukemia"},{"key":"5782_CR24","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood-2020-142349","volume":"136","author":"D Pang","year":"2020","unstructured":"Pang D, Jiang X, Huang L, Teng Y, Liu S, Chen F et al (2020) Ctdna monitoring in predicting relapse of primary mediastinal B-Cell lymphoma. Blood 136:36","journal-title":"Blood"},{"issue":"7","key":"5782_CR25","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/diagnostics12071575","volume":"12","author":"A Rivas-Delgado","year":"2022","unstructured":"Rivas-Delgado A, Nadeu F, Andrade-Campos M, L\u00f3pez C, Enjuanes A, Mozas P et al (2022) Cell-free DNA for genomic analysis in primary Mediastinal large B-Cell lymphoma. Diagnostics 12(7):1575","journal-title":"Diagnostics"},{"issue":"2","key":"5782_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1158\/1078-0432.CCR-20-2558","volume":"27","author":"A Rivas-Delgado","year":"2021","unstructured":"Rivas-Delgado A, Nadeu F, Enjuanes A, Casanueva-Eliceiry S, Mozas P, Magnano L et al (2021) Mutational landscape and tumor burden assessed by cell-free DNA in diffuse large B-cell lymphoma in a population-based study. Clin Cancer Res 27(2):513\u2013521","journal-title":"Clin Cancer Res"},{"issue":"15","key":"5782_CR27","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114\u20132120","journal-title":"Bioinformatics"},{"issue":"5","key":"5782_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491\u2013498","journal-title":"Nat Genet"},{"issue":"14","key":"5782_CR29","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25(14):1754\u20131760","journal-title":"Bioinformatics"},{"issue":"1","key":"5782_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-15-732","volume":"15","author":"KC Amarasinghe","year":"2014","unstructured":"Amarasinghe KC, Li J, Hunter SM, Ryland GL, Cowin PA, Campbell IG et al (2014) Inferring copy number and genotype in tumour exome data. BMC Genomics 15(1):1\u201312","journal-title":"BMC Genomics"},{"issue":"23","key":"5782_CR31","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1093\/bioinformatics\/btu549","volume":"30","author":"AM Newman","year":"2014","unstructured":"Newman AM, Bratman SV, Stehr H, Lee LJ, Liu CL, Diehn M et al (2014) FACTERA: a practical method for the discovery of genomic rearrangements at breakpoint resolution. Bioinformatics 30(23):3390\u20133393","journal-title":"Bioinformatics"},{"issue":"7996","key":"5782_CR32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-023-06903-x","volume":"625","author":"SK Alig","year":"2024","unstructured":"Alig SK, Shahrokh Esfahani M, Garofalo A, Li MY, Rossi C, Flerlage T et al (2024) Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling. Nature 625(7996):778\u2013787","journal-title":"Nature"},{"issue":"22","key":"5782_CR33","first-page":"2454","volume":"131","author":"E Tiacci","year":"2018","unstructured":"Tiacci E, Ladewig E, Schiavoni G, Penson A, Fortini E, Pettirossi V et al (2018) Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma. Blood J Am Soc Hematol 131(22):2454\u20132465","journal-title":"Blood J Am Soc Hematol"},{"issue":"6","key":"5782_CR34","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/bloodadvances.2021006415","volume":"6","author":"AF Herrera","year":"2022","unstructured":"Herrera AF, Tracy S, Croft B, Opat S, Ray J, Lovejoy AF et al (2022) Risk profiling of patients with relapsed\/refractory diffuse large B-cell lymphoma by measuring circulating tumor DNA. Blood Adv 6(6):1651\u20131660","journal-title":"Blood Adv"},{"issue":"4","key":"5782_CR35","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/cancers13040682","volume":"13","author":"MM Brune","year":"2021","unstructured":"Brune MM, Juskevicius D, Haslbauer J, Dirnhofer S, Tzankov A (2021) Genomic landscape of Hodgkin lymphoma. Cancers 13(4):682","journal-title":"Cancers"},{"issue":"4","key":"5782_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1200\/JCO.23.01053","volume":"42","author":"D Noerenberg","year":"2024","unstructured":"Noerenberg D, Briest F, Hennch C, Yoshida K, Hablesreiter R, Takeuchi Y et al (2024) Genetic characterization of primary mediastinal B-cell lymphoma: pathogenesis and patient outcomes. J Clin Oncol 42(4):452\u2013466","journal-title":"J Clin Oncol"},{"issue":"23","key":"5782_CR37","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J et al (2019) Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv 3(23):4065\u20134080","journal-title":"Blood Adv"},{"issue":"1","key":"5782_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41375-019-0541-6","volume":"34","author":"A-K Desch","year":"2020","unstructured":"Desch A-K, Hartung K, Botzen A, Brobeil A, Rummel M, Kurch L et al (2020) Genotyping circulating tumor DNA of pediatric Hodgkin lymphoma. Leukemia 34(1):151\u2013166","journal-title":"Leukemia"},{"issue":"34","key":"5782_CR39","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1200\/JCO.19.01389","volume":"37","author":"P Armand","year":"2019","unstructured":"Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G et al (2019) Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma. J Clin Oncol 37(34):3291","journal-title":"J Clin Oncol"},{"issue":"23","key":"5782_CR40","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1200\/JCO.2016.66.4482","volume":"34","author":"MG Roemer","year":"2016","unstructured":"Roemer MG, Advani RH, Ligon AH, Natkunam Y, Redd RA, Homer H et al (2016) PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol 34(23):2690","journal-title":"J Clin Oncol"},{"issue":"11","key":"5782_CR41","doi-asserted-by":"publisher","first-page":"e0166266","DOI":"10.1371\/journal.pone.0166266","volume":"11","author":"S Vranic","year":"2016","unstructured":"Vranic S, Ghosh N, Kimbrough J, Bilalovic N, Bender R, Arguello D et al (2016) PD-L1 status in refractory lymphomas. PLoS ONE 11(11):e0166266","journal-title":"PLoS ONE"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05782-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T09:05:12Z","timestamp":1729933512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05782-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":42,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["5782"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05782-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]},"assertion":[{"value":"5 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"M Zhu, X Zhao, L Shen, and Q Ou are employees of Nanjing Geneseeq Technology Inc., China. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by Ethics Committee of the Cancer Hospital of Shantou University Medical College (No. 2023059). All patients signed informed consent forms prior to enrollment and sample collection.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"M Zhu, X Zhao, L Shen, and Q Ou are employees of Nanjing Geneseeq Technology Inc., China. The remaining authors have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}